Selective tumour necrosis factor receptor-1 inhibition in acute lung injury: a new hope or a false dawn?

Thorax. 2018 Aug;73(8):699-701. doi: 10.1136/thoraxjnl-2017-211443. Epub 2018 Mar 22.

Authors

Pratik Sinha¹, Lorraine B Ware²

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California, USA.
² Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

PMID: 29567751
DOI: 10.1136/thoraxjnl-2017-211443

No abstract available

Keywords: ards.

Publication types

Editorial
Comment

MeSH terms

Acute Lung Injury*
Humans
Pneumonia
Receptors, Tumor Necrosis Factor, Type I*

Substances

Receptors, Tumor Necrosis Factor, Type I